Background Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) has caused a pandemic of pneumonia spreading around the world, leading to serious threats to public health and attracting enormous attention. There is an urgent need for sensitive diagnostic testing implementation to control and manage SARS-CoV-2 in public health laboratories. The quantitative reverse transcription PCR (RT-qPCR) assay is the gold standard method, but the sensitivity and specificity of SARS-CoV-2 testing are dependent on a number of factors. Methods We synthesized RNA based on the genes published to estimate the concentration of inactivated virus samples in a biosafety level 3 laboratory. The limit of detection (LOD), linearity, accuracy, and precision were evaluated according to the bioanalytical method validation guidelines. Results We found that the LOD reached around 3 copies/reaction. Furthermore, intra-assay precision, accuracy, and linearity met the accepted criterion with an RSD for copies of less than 25%, and linear regression met the accepted R 2 of 0.98. Conclusions We suggest that synthesized RNA based on the database of the NCBI gene bank for estimating the concentration of inactivated virus samples provides a potential opportunity for reliable testing to diagnose coronavirus disease 2019 (COVID-19) as well as limit the spread of the disease. This method may be relatively quick and inexpensive, and it may be useful for developing countries during the pandemic era. In the long term, it is also applicable for evaluation, verification, validation, and external quality assessment.
【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, public health, SARS-CoV-2, Coronavirus disease 2019, coronavirus, pandemic, Pneumonia, threat, diagnostic, severe acute respiratory syndrome Coronavirus, database, Laboratory, Spread, RT-qPCR, Accuracy, Sensitivity and specificity, SARS-CoV-2 testing, implementation, limit of detection, diagnostic testing, Factors, pandemic era, gold, Linear regression, respiratory, reverse transcription PCR, Quantitative, diagnose, inactivated, Concentration, long term, linearity, biosafety level, level 3, acute respiratory syndrome, Precision, acute respiratory syndrome coronavirus, gold standard, criterion, NCBI, verification, biosafety level 3 laboratory, Bioanalytical Method Validation, country, limit, Biosafety Level 3, Result, caused, the disease, evaluated, provide, less, dependent on, reached, R 2, synthesized RNA, virus sample, 【제목키워드】 Production, coronavirus 2, Testing, validation, Sample, Period, Developing,